IG wants benchmark pricing for drugs

Share this content:

The Department of Health and Human Services Office of Inspector General would like to see a national drug pricing benchmark. In a letter to the Centers for Medicare & Medicaid Services, the IG said the move save on Medicaid reimbursement costs paid to pharmacies. The letter said most states use a “fundamentally flawed” method to calculate such payments. The report said CMS is in agreement and is taking steps to provide guidance to states on this issue.


close

Next Article in Products